Strategic appointment to drive biotech expansion

Nuclera, the innovative biotech company advancing protein expression and optimisation with its cutting-edge eProtein Discovery™ system, has appointed Seth Benson as Chief Financial Officer (CFO). Benson, joining CEO Dr Michael Chen and the executive team, will play a key role in propelling the company’s commercial growth following a successful USD $75 million financing round.

Benson’s extensive financial expertise, with over 20 years in the life sciences and healthcare sectors, will be crucial in advancing Nuclera’s strategic expansion. With a solid background in driving strategic growth, optimising operations, and leading high-level financial initiatives, Benson has a proven track record of scaling companies and navigating complex financial landscapes. He has been instrumental in fundraising, acquisitions, restructurings, and IPOs, having previously contributed to Akoya Biosciences’ growth to over 300 employees and its eventual IPO.

Before joining Nuclera, Benson served as CFO at Vizgen, where he oversaw the company’s finances and guided it through the acquisition of Ultivue, a leader in spatial proteomics. Additionally, he held senior roles at Invaio Sciences, managing multi-national finance teams during key product launches and fundraising rounds. His career also includes investment banking positions at Morgan Stanley and Bank of America Merrill Lynch. Benson holds an MBA from Northwestern University’s Kellogg School of Management and a BSc in Biology from Duke University.

Benson expressed his enthusiasm for joining Nuclera, saying: “I’m thrilled to join Nuclera at such a dynamic time. The eProtein Discovery system is poised to revolutionise protein production workflows, and I’m excited to work with the team to drive growth and expand our global impact.”

CEO Dr Michael Chen commented, “Seth’s wealth of experience in scaling high-growth life science companies will be invaluable as we accelerate our commercial efforts. We also extend our gratitude to Jiahao for his significant contributions to Nuclera’s success since its founding in 2013.”

More information online